// App-Quantinova.ai

: DIACC2010, Sole-in-Class Selective Inhibitor of Kinesin KIF20A, Has Potent Preclinical Efficacy in Acute Myeloid Leukemia

Researchers

Presenter

  • Sylvain Garciaz

Principal Investigators

  • Yves Collette

  • Remy Castellano

  • Michel Aurrand-Lions

  • Helene Sicard

  • Laetitia Jentreau

  • Norbert Vey

  • Cecile Bougeret

Medical Centers

  • TrGET Platform, CRCM, Marseille, France

  • Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France; Centre National de la Recherche Scientifique, UMR, Marseille, France; Centre de Recherche en Cancérologie de Marseille, INSERM U, Marseille, France, Marseille, France

  • Institut Paoli-Calmettes, Aix-Marseille University, UM , Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U, CNRS UMR, Marseille, France

  • R&D, Diaccurate SA, Paris, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Annexin V

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Efficacy

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved